gliptin and glp-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? GLP-1 Medications – Community Education

We first asked participants whether they thought the growing popularity of GLP-1 drugs will change Americans dietary preferences and food purchasing habits

Premium Plus adds AI Coach (including conversational GLP-1 guidance), AI Restaurant Menu Scan, and AI Voice logging

Lotte Bjerre Knudsen, the legendary Chief Scientific Advisor at Novo Nordisk and the driving force behind the development of semaglutide (recently recognized with the 2025 Breakthrough Prize), took the stage

GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion whilst simultaneously suppressing glucagon release from alpha cells